Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O (2022) Advances in the management of peritoneal malignancies. Nat Rev Clin Oncol 19(11):698–718. https://doi.org/10.1038/s41571-022-00675-5

Article  PubMed  Google Scholar 

Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29–42. https://doi.org/10.1097/00000658-199501000-00004

Article  CAS  PubMed  PubMed Central  Google Scholar 

González-Moreno S (2006) Peritoneal surface oncology: a progress report. Eur J Surg Oncol 32(6):593–596. https://doi.org/10.1016/j.ejso.2006.03.001

Article  PubMed  Google Scholar 

Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, François Y, Vignal J, Gilly FN (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363. https://doi.org/10.1002/(sici)1097-0142(20000115)88:2%3c358::aid-cncr16%3e3.0.co;2-o

Article  CAS  PubMed  Google Scholar 

Cortés-Guiral D, Hübner M, Alyami M, Bhatt A, Ceelen W, Glehen O, Lordick F, Ramsay R, Sgarbura O, Van Der Speeten K, Turaga KK, Chand M (2021) Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers 7(1):91. https://doi.org/10.1038/s41572-021-00326-6

Article  PubMed  Google Scholar 

Bhatt A, Mehta S, Seshadri RA. 2019 The current status of peritoneal surface oncology in India. Indian J Surg Oncol. (Suppl 1):41–48. https://doi.org/10.1007/s13193-018-00871-9

Bhatt A, Mehta S, Ramakrishnan As, Pande P, Rajan F, Rangole A, Saklani A, Sethna K, Singh S, Zaveri S, Gopinath KS. 2017 Setting up of the Indian HIPEC Registry: a registry for Indian patients with peritoneal surface malignancies. Indian J Surg Oncol. (4):527–532. https://doi.org/10.1007/s13193-017-0693-7

Bhatt A, Mehta SS, Zaveri S, Rajan F, Ray M, Sethna K, Katdare N, Patel MD, Kammar P, Prabhu R, Sinukumar S, Mishra S, Rangarajan B, Rangole A, Damodaran D, Penumadu P, Ganesh M, Peedicayil A, Raj H, Seshadri R (2018) Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry. Int J Hyperthermia 35(1):361–369. https://doi.org/10.1080/02656736.2018.1503345

Article  PubMed  Google Scholar 

Moran BJ, Tzivanakis A (2018) The concept of “obstruction-free survival” as an outcome measure in advanced colorectal cancer management. Pleura Peritoneum 3(1):20180101. https://doi.org/10.1515/pp-2018-0101

Article  PubMed  PubMed Central  Google Scholar 

Goéré D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065–1071. https://doi.org/10.1097/SLA.0b013e31827e9289

Article  PubMed  Google Scholar 

Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K, Bereder JM, Arvieux C, Boschetti G, Glehen O (2016) BIG RENAPE Group. Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol. 23(6):1971–1979. https://doi.org/10.1245/s10434-015-5081-3

Article  CAS  PubMed  Google Scholar 

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456. https://doi.org/10.1200/JCO.2011.39.7166

Article  PubMed  Google Scholar 

Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer Academic publishers, Boston, pp 359–374

Chapter  Google Scholar 

Common terminology criteria for adverse events (CTCAE) https://www.eortc.be › services › doc › ctc › ctcae_4.... Accessed 20th December, 2022

Sinukumar S, Mehta S, As R, Damodaran D, Ray M, Zaveri S, Kammar P, Bhatt A (2019) Analysis of clinical outcomes of pseudomyxoma peritonei from appendicular origin following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-a retrospective study from INDEPSO. Indian J Surg Oncol. 10(Suppl 1):65–70. https://doi.org/10.1007/s13193-018-00870-w

Article  PubMed  PubMed Central  Google Scholar 

Bhatt A, Kammar P, Mehta S, Damodaran D, Zaveri S, Patel MD, Sinukumar S, Ray M, Seshadri R. 2019 Chasing rainbows? The possibility of “cure” in patients with colorectal peritoneal metastases undergoing cytoreductive surgery and HIPEC-a retrospective study by INDEPSO.Indian J Surg Oncol. (Suppl 1):49–56. https://doi.org/10.1007/s13193-019-00879-9

Piñeros M, Abriata MG, de Vries E, Barrios E, Bravo LE, Cueva P, de Camargo CM, Fernández L, Gil E, Luciani S, Pardo C, Zoss W, Bray F, Mery L (2021) Progress, challenges and ways forward supporting cancer surveillance in Latin America. Int J Cancer 149(1):12–20. https://doi.org/10.1002/ijc.33407

Article  CAS  PubMed  Google Scholar 

Pinheiro PS, Morris CR, Liu L, Bungum TJ, Altekruse SF (2014) The impact of follow-up type and missed deaths on population-based cancer survival studies for Hispanics and Asians. J Natl Cancer Inst Monogr 2014(49):210–217. https://doi.org/10.1093/jncimonographs/lgu016

Article  PubMed  PubMed Central  Google Scholar 

Kusamura S, Barretta F, Yonemura Y, Sugarbaker PH, Moran BJ, Levine EA, Goere D, Baratti D, Nizri E, Morris DL, Glehen O, Sardi A, Barrios P, Quénet F, Villeneuve L, Gómez-Portilla A, de Hingh I, Ceelen W, Pelz JOW, Piso P, González-Moreno S, Van Der Speeten K, Deraco M (2021) Peritoneal Surface Oncology Group International (PSOGI) and the French National Registry of Rare Peritoneal Surface Malignancies (RENAPE) The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery. JAMA Surg 156(3):e206363. https://doi.org/10.1001/jamasurg.2020.6363

Article  PubMed  PubMed Central  Google Scholar 

Habinshuti P, Hagenimana M, Nguyen C, Park PH, Mpunga T, Shulman LN, Fehr A, Rukundo G, Bigirimana JB, Teeple S, Kigonya C, Ndayisaba GF, Uwinkindi F, Randall T, Miller AC (2020) Factors associated with loss to follow-up among cervical cancer patients in Rwanda. Ann Glob Health 86(1):117. https://doi.org/10.5334/aogh.2722

Article  PubMed  PubMed Central  Google Scholar 

Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G (2018) Ninety-day post-operative morbidity and mortality using the National Cancer Institute’s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia 34(5):532–537. https://doi.org/10.1080/02656736.2017.1367846

Article  PubMed  Google Scholar 

Rau B, Brandl A, Piso P et al (2020) Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer 23:11–22. https://doi.org/10.1007/s10120-019-00978-0

Article  PubMed  Google Scholar 

Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M (2013) Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer 49(15):3140–3148. https://doi.org/10.1016/j.ejca.2013.05.027

Article  PubMed  Google Scholar 

Kusamura S, Torres Mesa PA, Cabras A, Baratti D, Deraco M (2016) The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 23(5):1468–1473. https://doi.org/10.1245/s10434-015-4962-9

Article  PubMed  Google Scholar 

Cazauran JB, Lasseur A, Pasquer A et al (2017) Total mesenteric peritonectomy for peritoneal metastases (with video). Ann Surg Oncol. https://doi.org/10.1245/s10434-017-6099-5

Article  PubMed  Google Scholar 

Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20(5):1248–1259. https://doi.org/10.1200/JCO.2002.20.5.1248

Article  PubMed  Google Scholar 

Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D’Angelica MI, Barakat RR, Chi DS (2006) The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 103(3):1083–1090. https://doi.org/10.1016/j.ygyno.2006.06.028

Article  PubMed  Google Scholar 

Fagotti A, Ferrandina MG, Vizzielli G, Pasciuto T, Fanfani F, Gallotta V, Margariti PA, Chiantera V, Costantini B, GueliAlletti S, Cosentino F, Scambia G (2020) Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). Int J Gynecol Cancer 30(11):1657–1664. https://doi.org/10.1136/ijgc-2020-001640

Article  PubMed  Google Scholar 

Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgaard BJ, Selle F, Guyon F, Pomel C, Lécuru F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Kristensen G, Classe JM, Hillemanns P, Jensen P, Hasenburg A, Ghaem-Maghami S, Mirza MR, Lund B, Reinthaller A, Santaballa A, Olaitan A, Hilpert F, du Bois A (2021) DESKTOP III Investigators. Randomized trial of cytoreductive surgery for relapsed ovarian cancer. N Engl J Med 385(23):2123–2131. https://doi.org/10.1056/NEJMoa2103294. Erratum.In:NEnglJMed.386(7):704

Article  PubMed  Google Scholar